Chronic Hepatitis B Virus and Hepatitis D Virus: New Developments
Overview
Authors
Affiliations
Hepatitis B virus (HBV) and hepatitis D virus are leading causes of morbidity and mortality worldwide. Despite the availability of HBV vaccinations that are 98% to 100% effective, an estimated 820,000 annual deaths were attributed to HBV in 2019, mainly related to the sequelae of cirrhosis and hepatocellular carcinoma. Because disease prevalence is concentrated outside of the United States, it is overlooked, but with expanded vaccination recommendations provided by the Centers for Disease Control and Prevention and recommended screening, as well as heightened awareness by health care providers, we can work toward the eradication of this preventable disease.
Chu S, Chen Y, Wang Y BMC Gastroenterol. 2025; 25(1):82.
PMID: 39955486 PMC: 11830201. DOI: 10.1186/s12876-025-03672-x.
Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives.
Yang S, Zou Y, Zhong C, Zhou Z, Peng X, Tang C Front Cell Dev Biol. 2025; 13:1522206.
PMID: 39917567 PMC: 11798966. DOI: 10.3389/fcell.2025.1522206.
Zhou Y, Shen Y, He J, Yang X Am J Transl Res. 2025; 16(12):7591-7599.
PMID: 39822557 PMC: 11733369. DOI: 10.62347/RKNH8649.
The role of inflammasome in chronic viral hepatitis.
Wan P, Yang G, Cheng Q, Zhang X, Yue Z, Li M Front Cell Infect Microbiol. 2024; 14:1382029.
PMID: 38817443 PMC: 11137247. DOI: 10.3389/fcimb.2024.1382029.
Delta Hepatitis in the United States: Epidemiology, Testing, and Linkage to Care.
Gish R Gastroenterol Hepatol (N Y). 2024; 19(10):603-605.
PMID: 38404959 PMC: 10882855.